The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 16, 2022

Filed:

Dec. 18, 2019
Applicant:

Morehouse School of Medicine, Atlanta, GA (US);

Inventors:

Michael D. Powell, Douglasville, GA (US);

Erick Vidjin′ Agnih Gbodossou, Dakar-Etoile, SN;

Assignee:

MOREHOUSE SCHOOL OF MEDICINE, Atlanta, GA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 36/42 (2006.01); A61K 9/14 (2006.01); A61P 31/18 (2006.01); A61K 9/20 (2006.01); A61K 38/10 (2006.01); A61K 9/48 (2006.01);
U.S. Cl.
CPC ...
A61K 36/42 (2013.01); A61K 9/14 (2013.01); A61K 9/20 (2013.01); A61K 9/48 (2013.01); A61K 38/10 (2013.01); A61P 31/18 (2018.01);
Abstract

The present application relates to a compositions and methods comprising or expressing a MOMO30 protein derived from. The MOMO30 protein is about 30 kDa in size, is stable after being autoclaved at 120° C. for 30 min, resists proteolytic cleavage by trypsin, exhibits mannose-sensitive binding HIV gp120, exhibits hemagglutinin and chitinase activity, is capable of activating and stimulating T cell proliferation, is capable of preventing infection by HIV-1 or alleviating symptoms in an HIV-1 infected patients and comprises the amino acid sequence of SEQ ID NO: 1. The MOMO30 protein and/or a nucleic acid encoding the same may be used in methods for preventing or treating viral infections by HIV and other enveloped viruses.


Find Patent Forward Citations

Loading…